Exo Imaging, Inc. has purchased all outstanding shares of Medo DX PTE. Ltd., an artificial intelligence and machine learning company based in Singapore and Alberta that operates in the medical imaging sector in North America.

The Bennett Jones team acted as lead counsel and key advisor to Medo DX Pte. Ltd. and their Albertan subsidiary, Medo.ai Inc., in all aspects of this transaction, requiring substantial international coordination with multiple investor sellers in Singapore and navigating  the jurisdictions of Delaware, Singapore and Canada.

Read more about this sale on Business Wire.